KRMD · KORU Medical Systems, Inc.
$4.07
+0.06 (+1.50%)
At close · Jul 29
Market Cap
$184.19M
Shares
45.93M
KORU Medical Systems, Inc. Earnings Call Transcripts
Every quarterly earnings call for KORU Medical Systems, Inc. (KRMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲28.5%
$7.76M
−$1.23M
'22 Q3
22-11-09
▲13.2%
$7.34M
−$1.98M
'22 Q4
23-03-08
▲18.4%
$7.39M
−$2.41M
'23 Q1
23-05-04
▲5.9%
$6.94M
−$2.50M
'23 Q2
23-08-09
▼9.8%
$7.00M
−$1.37M
'23 Q3
23-11-08
▼2.2%
$7.19M
−$7.47M
'23 Q4
24-03-13
▲10.9%
$8.20M
−$1.94M
'24 Q1
24-05-01
▲21.5%
$8.43M
−$988,715
'24 Q2
24-08-07
▲16.8%
$8.18M
−$1.58M
'24 Q3
24-11-13
▲23%
$8.84M
−$1.56M
'24 Q4
25-03-12
▲17.5%
$9.64M
−$1.17M
'25 Q1
25-05-07
▲20.9%
$10.19M
−$206,867
'25 Q2
25-08-06
▲27.2%
$10.40M
−$777,966
'25 Q3
25-11-12
▲23.3%
$10.90M
−$486,856
'25 Q4
26-03-12
LATEST
▲22.1%
$11.76M
−$807,078
'26 Q1
26-05-06
Conference
Investor event
2026-08-12
Canaccord Genuity 46th Annual Growth Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-05
Second Quarter 2026 Financial Results Conference Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
KORU Medical Systems, Inc. Q1 FY2026 Earnings Call
Confident tone
SID (secondary immunodeficiency) opportunity
Non-IG pipeline and drug expansion
Domestic core business growth
Revenue
$11.76M
▲ 22.1% YoY Diluted EPS
$-0.02
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
KORU Medical Systems, Inc. Q4 FY2025 Earnings Call
Confident tone
Revenue growth and full year results
RYSTIGGO and infusion clinic channel
2026 guidance and outlook
Revenue
$10.90M*
▲ 23.3% YoY Gross margin
62.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
KORU Medical Systems, Inc. Q3 FY2025 Earnings Call
Confident tone
US SCIG Core Business
International Expansion and Prefilled Syringes
Oncology Infusion Opportunity
Revenue
$10.40M
▲ 27.2% YoY Diluted EPS
$0.02
▼ 33.3% YoY Gross margin
60.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
KORU Medical Systems, Inc. Q2 FY2025 Earnings Call
Confident tone
Guidance and Forward Outlook
Core Domestic Business
New Drug Pipeline and Label Expansions
Revenue
$10.19M
▲ 20.9% YoY Diluted EPS
$0.00
▼ 100% YoY Gross margin
63.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
KORU Medical Systems, Inc. Q1 FY2025 Earnings Call
Confident tone
International expansion
Tariffs and gross margin
510(k) submissions and new drugs on label pipeline
Revenue
$9.64M
▲ 17.5% YoY Diluted EPS
$-0.03
▼ 175% YoY Gross margin
62.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
KORU Medical Systems, Inc. Q4 FY2024 Earnings Call
Confident tone
International Expansion
Domestic Core Business and SCIg Market
Tariffs and Supply Chain
Revenue
$8.84M*
▲ 23% YoY Gross margin
62.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
KORU Medical Systems, Inc. Q3 FY2024 Earnings Call
Confident tone
Novel Therapies Pipeline
Domestic Core SCIg Business
International Expansion
Revenue
$8.18M
▲ 16.8% YoY Diluted EPS
$0.03
Gross margin
63.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
KORU Medical Systems, Inc. Q2 FY2024 Earnings Call
Confident tone
International Expansion
Novel Therapies / Pipeline Collaborations
Core Domestic SCIg Business Growth
Revenue
$8.43M
▲ 21.5% YoY Diluted EPS
$0.02
Gross margin
65.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
KORU Medical Systems, Inc. Q1 FY2024 Earnings Call
Confident tone
Novel Therapies pipeline and collaborations
International expansion and BSI/MDR regulatory progress
2024 guidance reaffirmation
Revenue
$8.20M
▲ 10.9% YoY Diluted EPS
$0.04
Gross margin
62.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-13
KORU Medical Systems, Inc. Q4 FY2023 Earnings Call
Positive tone
Novel Therapies Pipeline
International Expansion
Domestic SCIg Core Business
Revenue
$7.19M*
▼ 2.2% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
KORU Medical Systems, Inc. Q3 FY2023 Earnings Call
Revenue
$7.00M
▼ 9.8% YoY Diluted EPS
$-0.03
Gross margin
62.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
KORU Medical Systems, Inc. Q2 FY2023 Earnings Call
Revenue
$6.94M
▲ 5.9% YoY Diluted EPS
$-0.05
Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
KORU Medical Systems, Inc. Q1 FY2023 Earnings Call
Revenue
$7.39M
▲ 18.4% YoY Diluted EPS
$-0.05
Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
KORU Medical Systems, Inc. Q4 FY2022 Earnings Call
Revenue
$7.34M*
▲ 13.2% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
KORU Medical Systems, Inc. Q3 FY2022 Earnings Call
Revenue
$7.76M
▲ 28.5% YoY Diluted EPS
$-0.03
Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
KORU Medical Systems, Inc. Q2 FY2022 Earnings Call
Revenue
$6.55M
▲ 18.4% YoY Diluted EPS
$-0.07
Gross margin
51.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
KORU Medical Systems, Inc. Q1 FY2022 Earnings Call
Revenue
$6.24M
▲ 15% YoY Diluted EPS
$-0.06
Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-02
KORU Medical Systems, Inc. Q4 FY2021 Earnings Call
Revenue
$6.49M*
▲ 60% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
KORU Medical Systems, Inc. Q3 FY2021 Earnings Call
Revenue
$6.04M
▼ 0.7% YoY Diluted EPS
$-0.02
▼ 300% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
KORU Medical Systems, Inc. Q2 FY2021 Earnings Call
Revenue
$5.53M
▼ 28.3% YoY Diluted EPS
$-0.03
Gross margin
58.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
KORU Medical Systems, Inc. Q1 FY2021 Earnings Call
Revenue
$5.43M
▼ 14.2% YoY Diluted EPS
$-0.03
▼ 400% YoY Gross margin
59.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-26
KORU Medical Systems, Inc. Q4 FY2020 Earnings Call
Revenue
$4.06M*
▼ 34.8% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
KORU Medical Systems, Inc. Q3 FY2020 Earnings Call
Revenue
$6.08M
▼ 8.1% YoY Diluted EPS
$0.01
▼ 50% YoY Gross margin
64.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
KORU Medical Systems, Inc. Q2 FY2020 Earnings Call
Revenue
$7.71M
▲ 44.1% YoY Diluted EPS
$-0.03
Gross margin
63.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
KORU Medical Systems, Inc. Q1 FY2020 Earnings Call
Revenue
$6.33M
▲ 27.3% YoY Diluted EPS
$0.01
Gross margin
59.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
KORU Medical Systems, Inc. Q4 FY2019 Earnings Call
Revenue
$6.22M*
▲ 45.7% YoY Gross margin
63.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls